🇺🇸 FDA
Patent

US 7169798

Inhibitors of c-Jun N terminal kinases (JNK) and other protein kinases

granted A61KA61K31/341A61K31/4155

Quick answer

US patent 7169798 (Inhibitors of c-Jun N terminal kinases (JNK) and other protein kinases) held by Vertex Pharmaceuticals Incorporated expires Mon Jan 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Jan 30 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/341, A61K31/4155, A61K31/4192, A61K31/42